Ultragenyx Announces First Patient Enrolled in Global Phase 3 Study of KRN23 in Pediatric Patients with X-Linked Hypophosphatemia (XLH)
/
Date26 Oct 2016
NOVATO, Calif, Oct. 26, 2016 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and... Read More →
Dr. Khaldoun F. Ajlouni Wins the Private Practice Prosthodontist Award for Rockies/Plains Region 4 from the American College of Prosthodontists
/
Date26 Oct 2016
CHICAGO, Oct. 26, 2016 (GLOBE NEWSWIRE) — Khaldoun F. Ajlouni, DDS, MS, was honored with the Private Practice Prosthodontist Award for Rockies/Plains Region 4 for... Read More →
Minerva Neurosciences Announces Positive Data From Six-Month Extension of Phase IIb Trial of MIN-101 Monotherapy in Schizophrenia
/
Date26 Oct 2016
MIN-101C03: Negative Symptoms (Pentagonal Structure) WALTHAM, Mass., Oct. 26, 2016 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development... Read More →
Melinta Therapeutics’ Baxdela™ to be Featured in Six Poster Presentations at IDWeek 2016™
/
Date26 Oct 2016
NEW ORLEANS, Oct. 26, 2016 (GLOBE NEWSWIRE) — Melinta Therapeutics, a privately held company exclusively focused on developing novel antibiotics to treat serious bacterial infections,... Read More →
Kessler Foundation Study Explores Mindfulness-based Therapy in Children and Adolescents with Brain Injury
/
Date26 Oct 2016
EAST HANOVER, N.J., Oct. 26, 2016 (GLOBE NEWSWIRE) — Kessler Foundation and Children’s Specialized Hospital are actively recruiting children and adolescents with brain injury for... Read More →
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
/
Date26 Oct 2016
– Incoming specialists to focus on Quality Control and Quality Assurance Aspects of Supply Chain NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals,... Read More →
Anti-Aging Market Set for Rapid Growth to Reach $216.52 Billion, Globally by 2021: Zion Market Research
/
Date26 Oct 2016
Sarasota, FL, Oct. 26, 2016 (GLOBE NEWSWIRE) — According to the report published by Zion Market Research, global demand for anti-aging market was valued at USD 140.3... Read More →
NewLink Genetics Shares Its Immuno-Oncology Strategy 2016 Analyst and Investor Day
/
Date25 Oct 2016
Two Distinct IDO Pathway Inhibitors in Clinical Development Indoximod, Exclusive to NewLink Genetics GDC-0919 in Partnership with Genentech, a Member of the Roche Group AMES,... Read More →
Globus Medical Launches QUARTEX™ OCT Stabilization System
/
Date25 Oct 2016
AUDUBON, Pa., Oct. 25, 2016 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, continues to innovate in the treatment of complex... Read More →
Kessler Foundation Study Aims to Improve Learning among Adolescents with Brain Injury
/
Date25 Oct 2016
EAST HANOVER, N.J., Oct. 25, 2016 (GLOBE NEWSWIRE) — Kessler Foundation, a global leader in rehabilitation research, and Children’s Specialized Hospital, the nation’s leading provider... Read More →